Denil N. Shekhat's most recent trade in Mira Pharmaceuticals Inc was a trade of 22,378 Common Stock done at an average price of $1.3 . Disclosure was reported to the exchange on Oct. 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Mira Pharma Inc | Denil Nanji Shekhat | Director | Grant, award, or other acquisition of securities at price $ 1.35 per share. | 01 Oct 2025 | 22,378 | 22,378 | - | 1.3 | 30,210 | Common Stock |
| Mira Pharma Inc | Denil Nanji Shekhat | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2024 | 50,000 | 50,000 | - | - | Stock Options (right to buy) | |
| Mira Pharma Inc | Denil Nanji Shekhat | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 50,000 | 41,666 | - | - | Nonqualified Stock Option (right to buy) | |
| Mira Pharma Inc | Denil N. Shekhat | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2024 | 50,000 | 25,000 | - | - | Nonqualified Stock Option (right to buy) |